2024-11-09 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

This report provides a comprehensive analysis of Intuitive Surgical Inc. (ISRG), a leading provider of robotic-assisted surgical systems. 

**1. Performance Comparison:**

ISRG has significantly outperformed the S&P 500 (VOO) over the period analyzed. The cumulative return for ISRG is 378.28%, compared to 141.71% for the S&P 500, resulting in a **236.57% outperformance**. This represents an **81.51%** position within the historical range of performance differences, indicating a strong relative performance.

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|---|---|---|---|---|
| 2015-2017 | 108.3% | 16.7% | 78.1% | 0.8 |
| 2016-2018 | 162.5% | 23.9% | 137.8% | 1.2 |
| 2017-2019 | 176.3% | 23.9% | 133.2% | 1.4 |
| 2018-2020 | 118.0% | 40.4% | 78.9% | 1.2 |
| 2019-2021 | 131.3% | 40.4% | 41.5% | 1.2 |
| 2020-2022 | 33.3% | 45.8% | 15.6% | 1.2 |
| 2021-2023 | 26.5% | 45.8% | -2.3% | 1.4 |
| 2022-2024 | 45.6% | 45.1% | 21.0% | 1.3 |

This analysis indicates ISRG generally outperforms the market (Alpha > 0), with consistent outperformance in most years. The beta values suggest ISRG's volatility is slightly higher than the market.

**2. Recent Price Action:**

* **Closing Price:** 524.28 (Last-market: 537.51)
* **5-day Moving Average:** 513.75
* **20-day Moving Average:** 505.39
* **60-day Moving Average:** 491.32

The stock is trading above all three moving averages, suggesting an upward trend. 

**3. Technical Indicators:**

* **RSI:** 53.22 - Slightly above the neutral level of 50, indicating the stock is neither overbought nor oversold.
* **PPO:** 0.1 - Positive PPO value suggests a bullish sentiment.
* **Delta_Previous_Relative_Divergence:** 7.51 (+) - A positive delta indicates short-term upward momentum.
* **Expected Return:** 12.6% - This is the expected long-term (2+ years) excess return over the S&P 500 based on current valuation and market sentiment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2024-10-18 | 1.18 | 1.74 B$ |

ISRG has been consistently exceeding revenue and earnings expectations, demonstrating strong growth. The company's recent earnings call provided an optimistic outlook for the future.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |
| 2023-09-30 | $1.74B | 66.94% |

ISRG has maintained a high and consistent profit margin, showcasing its strong business model and efficient operations.

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |
| 2023-09-30 | $12.54B | 3.32% |

The company's ROE has remained relatively stable, indicating a consistent ability to generate returns on equity.

**6. News and Recent Issues:**

* **Recent Earnings News:** ISRG's recent earnings report, released on [date of earnings release], exceeded analysts' expectations for both earnings and revenue, boosting investor sentiment.
* **Market Outlook:** According to various market analysts, ISRG is seen as a strong long-term investment due to its dominant position in the robotic surgery market and continued growth potential.
* **Analyst Opinions:** The majority of analysts have a "Buy" or "Strong Buy" rating on ISRG, reflecting their positive outlook on the company's future performance.

**7. Summary:**

ISRG has shown exceptional performance, outperforming the market consistently and exhibiting strong financial fundamentals. The company's market leadership, strong growth, and positive industry outlook suggest continued strong performance in the future. The current technical indicators suggest upward momentum, and the expected return of 12.6% over the S&P 500 makes ISRG an attractive long-term investment opportunity. 

**Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice. It is essential to conduct thorough research and consult with a qualified financial advisor before making any investment decisions.
